ABORTION PANEL Anti-HLA antibodies Test
Test Name: ABORTION PANEL Anti-HLA antibodies Test
Components: *CD3 *CD19 *CD16 + CD56 *TNF-alpha *HLA DR, DQA1 & DQB1 (Class II) Typing
Price: 4210.0 AED
Sample Condition: 2 mL (1 mL min.) serum from 1 SST AND 6 mL (4 mL min.) whole blood in 2 Lavender Top (EDTA) tubes AND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Clinical details on test request form are mandatory.
Report Delivery: 1 week
Method: Flow Cytometry, CLIA, PCR
Test type: Recurrent Abortions
Doctor: Gynecologist
Test Department:
Pre Test Information: Clinical details on test request form are mandatory.
Test Details
The topic of anti-HLA antibodies test is not directly related to abortion. Anti-HLA antibodies are antibodies that target human leukocyte antigens (HLAs), which are proteins found on the surface of cells in the body. These antibodies can develop in response to organ transplantation, blood transfusions, or pregnancy.
During pregnancy, anti-HLA antibodies can potentially cause complications such as miscarriage, fetal growth restriction, and preterm birth. In some cases, these antibodies can cross the placenta and attack the developing fetus’s cells, leading to adverse outcomes.
Testing for anti-HLA antibodies during pregnancy can help identify women at risk of these complications. The test involves taking a blood sample from the pregnant woman and testing it for the presence of these antibodies. If positive, further monitoring and interventions may be required to manage the potential risks.
However, it is important to note that the presence of anti-HLA antibodies does not directly determine the need for an abortion. The decision to terminate a pregnancy is a personal and complex one, often based on a variety of factors such as the health of the mother and the fetus, personal beliefs, and individual circumstances. The presence of anti-HLA antibodies may be one piece of information considered in the overall evaluation of the pregnancy, but it does not dictate the outcome.
| Test Name | ABORTION PANEL Anti-HLA antibodies Test |
|---|---|
| Components | *CD3 *CD19 *CD16 + CD56*TNF-alpha *HLA DR, DQA1 & DQB1 (Class II) Typing |
| Price | 4210.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST AND 6 mL (4 mL min.) whole blood in 2 Lavender Top (EDTA) tubesAND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube.Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Clinical details on test request form are mandatory. |
| Report Delivery | 1 week |
| Method | Flow Cytometry, CLIA, PCR |
| Test type | Recurrent Abortions |
| Doctor | Gynecologist |
| Test Department: | |
| Pre Test Information | Clinical details on test request form are mandatory. |
| Test Details |
The topic of anti-HLA antibodies test is not directly related to abortion. Anti-HLA antibodies are antibodies that target human leukocyte antigens (HLAs), which are proteins found on the surface of cells in the body. These antibodies can develop in response to organ transplantation, blood transfusions, or pregnancy. During pregnancy, anti-HLA antibodies can potentially cause complications such as miscarriage, fetal growth restriction, and preterm birth. In some cases, these antibodies can cross the placenta and attack the developing fetus’s cells, leading to adverse outcomes. Testing for anti-HLA antibodies during pregnancy can help identify women at risk of these complications. The test involves taking a blood sample from the pregnant woman and testing it for the presence of these antibodies. If positive, further monitoring and interventions may be required to manage the potential risks. However, it is important to note that the presence of anti-HLA antibodies does not directly determine the need for an abortion. The decision to terminate a pregnancy is a personal and complex one, often based on a variety of factors such as the health of the mother and the fetus, personal beliefs, and individual circumstances. The presence of anti-HLA antibodies may be one piece of information considered in the overall evaluation of the pregnancy, but it does not dictate the outcome. |
